Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 10X Genomics Inc (TXG) vs Upwork Inc (UPWK) Price & Performance

10X Genomics IncTrade
Upwork IncTrade

Price performance (Past 24H)

Key statistics

10X Genomics Inc vs Upwork Inc — how do they compare? 10X Genomics Inc trades at $57.01 (market cap $7.61B), while Upwork Inc trades at $8.31 (market cap $1.04B). The key difference: 10X Genomics Inc is far larger — about 7.3× Upwork Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Upwork Inc nearer its low. Which is the better fit depends on your goals.

TXGUPWK
Market Cap
$7.61B$1.04B
Sector
HealthIndustrials
52-Week High
$58.57$22.11
52-Week Low
$11.34$7.84
Enterprise Value
$7.14B$806.15M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

10X Genomics Inc

TXG (10x Genomics) trades at $56.95, down 2.77% on the day. The stock exhibits bullish technical signals with strong moving averages, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and a narrowing net loss margin from -41.23% in 2023 to -12.18% in 2026. Recent news highlights collaborations with Cleveland Clinic and acquisition of Proteintech Genomics, expanding multiomics capabilities.

Outlook: Growth potential exists through market expansion and innovation, but risks include persistent unprofitability and high valuation multiples. Analyst sentiment is mixed with a $46 consensus target below current price, indicating caution despite recent operational improvements.

Upwork Inc

UPWK is trading at $8.25, down 16.12% amid weak guidance overshadowing a recent Q2 earnings beat. The stock shows bearish technical signals with key support at $8.00. Fundamentally, revenue grew to $787.78M in 2025 with a net income margin of 12.93%, though earnings have been mixed with three misses in the last four quarters. Recent news highlights concerns over declining active clients and AI-driven market shifts.

The outlook is cautious; while valuation ratios like P/E of 10.71 appear reasonable, near-term risks from competitive pressures and investor lawsuits pose headwinds. Analyst consensus is a Buy with a $9.25 target, suggesting potential upside if execution improves, but sentiment remains fragile post-earnings.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG

About Upwork Inc

Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.

Read more on UPWK